Please enable JavaScript to continue using this application.

Compare $ATRA vs $EQ | Chartloom

Compare

$ATRA vs $EQ

Atara Biotherapeutics Inc · Equillium Inc

ATRA

Atara Biotherapeutics Inc

Equillium Inc

Compare $ATRA vs $EQ

Comparing Atara Biotherapeutics Inc and Equillium Inc

ATRAAtara Biotherapeutics Inc

EQEquillium Inc

ATRAAtara Biotherapeutics Inc

Market cap

$85M

P/E (TTM)

—

Forward P/E (NTM)

14.78x

Forward P/S (NTM)

2.47x

Rev growth (TTM)

-96.7%

YTD performance

-46.7%

52W performance

-40.2%

FCF yield

-25.6%

EQEquillium Inc

Market cap

$89M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-7.8%

52W performance

-4.1%

FCF yield

-22.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ATRA

Detailed metrics comparison

ATRA

Atara Biotherapeutics Inc

Equillium Inc

Market Cap

ATRA$85M

EQ$89M

Enterprise Value

ATRA$124M

EQ$32M

Price

ATRA$9.48

EQ$1.41

P/E Ratio

ATRAN/A

EQN/A

P/S Ratio

ATRA13.79x

EQ2.18x

EV/Sales

ATRA19.98x

EQ0.78x

EV/EBITDA

ATRA3.51x

EQ0.00x

P/B Ratio

ATRA12.86x

EQ1.60x

P/FCF Ratio

ATRAN/A

EQN/A

EV/FCF

ATRA-5.65x

EQ-1.59x

PEG Ratio

ATRAN/A

EQN/A

Forward P/E (NTM)

ATRA14.78x

EQN/A

Forward P/S (NTM)

ATRA2.47x

EQN/A

Revenue (TTM)

ATRA$6M

EQ$0

Revenue Growth (YoY)

ATRA-96.7%

EQN/A

Forward Rev Growth

ATRA1983.2%

EQ0.0%

Gross Margin (TTM)

ATRA91.4%

EQ0.0%

Operating Margin (TTM)

ATRA0.0%

EQ0.0%

EBITDA Margin (TTM)

ATRA-194.7%

EQ0.0%

Net Margin (TTM)

ATRA-269.4%

EQ0.0%

FCF Margin (TTM)

ATRA-353.5%

EQN/A

Net Income (TTM)

ATRA$-17M

EQ$-18M

FCF (TTM)

ATRA$-22M

EQ$-20M

EPS (TTM)

ATRA-$1.11

EQ-$0.15

ROE (TTM)

ATRA-31542.0%

EQ-6143.0%

ROA (TTM)

ATRA-7301.0%

EQ-5372.0%

ROIC (TTM)

ATRA-30684.0%

EQ-6143.0%

Cash

ATRA$3M

EQ$57M

Debt

ATRA$42M

EQ$0

Net Cash/Debt

ATRA$-38M

EQ$57M

Current Ratio (TTM)

ATRA1.98x

EQ23.40x

Quick Ratio (TTM)

ATRA1.98x

EQ23.07x

Debt/Equity (TTM)

ATRA0.12x

EQ0.00x

Debt/Assets (TTM)

ATRA0.0%

EQ0.0%

Interest Coverage (TTM)

ATRAN/A

EQN/A

Net Debt/EBITDA (TTM)

ATRA0.00x

EQ0.00x

Beta

ATRA0.31

EQ2.07

52W Performance

ATRA-40.2%

EQ-4.1%

YTD Performance

ATRA-46.7%

EQ-7.8%

% from 52W High

ATRA-50.5%

EQ-60.2%

% from 52W Low

ATRA141.8%

EQ85.5%

Asset Turnover (TTM)

ATRA0.27x

EQ1.12x

FCF Yield (TTM)

ATRA-25.6%

EQ-22.5%

Earnings Yield (TTM)

ATRA-19.5%

EQ-20.2%

Dividend Yield (TTM)

ATRAN/A

EQN/A

Rule of 40

ATRA-450.2

EQ0.0

EV/GP/RG

ATRA0.05

EQN/A

Ticker research

View ATRA research View EQ research

Metric	ATRA Atara Biotherapeutics Inc	EQ Equillium Inc
Market & Valuation
Market Cap	$85M	$89M
Enterprise Value	$124M	$32M
Price	$9.48	$1.41
P/E Ratio	N/A	N/A
P/S Ratio	13.79x	2.18x
EV/Sales	19.98x	0.78x
EV/EBITDA	3.51x	0.00x
P/B Ratio	12.86x	1.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.65x	-1.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	14.78x	N/A
Forward P/S (NTM)	2.47x	N/A
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	-96.7%	N/A
Forward Rev Growth	1983.2%	0.0%
Profitability
Gross Margin (TTM)	91.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.7%	0.0%
Net Margin (TTM)	-269.4%	0.0%
FCF Margin (TTM)	-353.5%	N/A
Net Income (TTM)	$-17M	$-18M
FCF (TTM)	$-22M	$-20M
EPS (TTM)	-$1.11	-$0.15
ROE (TTM)	-31542.0%	-6143.0%
ROA (TTM)	-7301.0%	-5372.0%
ROIC (TTM)	-30684.0%	-6143.0%
Financial Health
Cash	$3M	$57M
Debt	$42M	$0
Net Cash/Debt	$-38M	$57M
Current Ratio (TTM)	1.98x	23.40x
Quick Ratio (TTM)	1.98x	23.07x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	2.07
52W Performance	-40.2%	-4.1%
YTD Performance	-46.7%	-7.8%
% from 52W High	-50.5%	-60.2%
% from 52W Low	141.8%	85.5%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	1.12x
FCF Yield (TTM)	-25.6%	-22.5%
Earnings Yield (TTM)	-19.5%	-20.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-450.2	0.0
EV/GP/RG	0.05	N/A
Ticker research	View ATRA research	View EQ research

Valuation

P/S Ratio

2.18x

ATRA

13.79x

EV/FCF

ATRA

-5.65x

-1.59x

Growth & revenue

Revenue Growth TTM

ATRA

-96.7%

Forward Revenue Growth

ATRA

1983.2%

0.0%

Profitability & performance

Gross Margin

ATRA

91.4%

0.0%

ROE

-6143.0%

ATRA

-31542.0%

FCF Yield %

-22.5%

ATRA

-25.6%

52-Week Performance

-4.1%

ATRA

-40.2%

Detailed metrics comparison

ATRA

Atara Biotherapeutics Inc

Equillium Inc

Market Cap

ATRA$85M

EQ$89M

Enterprise Value

ATRA$124M

EQ$32M

Price

ATRA$9.48

EQ$1.41

P/E Ratio

ATRAN/A

EQN/A

P/S Ratio

ATRA13.79x

EQ2.18x

EV/Sales

ATRA19.98x

EQ0.78x

EV/EBITDA

ATRA3.51x

EQ0.00x

P/B Ratio

ATRA12.86x

EQ1.60x

P/FCF Ratio

ATRAN/A

EQN/A

EV/FCF

ATRA-5.65x

EQ-1.59x

PEG Ratio

ATRAN/A

EQN/A

Forward P/E (NTM)

ATRA14.78x

EQN/A

Forward P/S (NTM)

ATRA2.47x

EQN/A

Revenue (TTM)

ATRA$6M

EQ$0

Revenue Growth (YoY)

ATRA-96.7%

EQN/A

Forward Rev Growth

ATRA1983.2%

EQ0.0%

Gross Margin (TTM)

ATRA91.4%

EQ0.0%

Operating Margin (TTM)

ATRA0.0%

EQ0.0%

EBITDA Margin (TTM)

ATRA-194.7%

EQ0.0%

Net Margin (TTM)

ATRA-269.4%

EQ0.0%

FCF Margin (TTM)

ATRA-353.5%

EQN/A

Net Income (TTM)

ATRA$-17M

EQ$-18M

FCF (TTM)

ATRA$-22M

EQ$-20M

EPS (TTM)

ATRA-$1.11

EQ-$0.15

ROE (TTM)

ATRA-31542.0%

EQ-6143.0%

ROA (TTM)

ATRA-7301.0%

EQ-5372.0%

ROIC (TTM)

ATRA-30684.0%

EQ-6143.0%

Cash

ATRA$3M

EQ$57M

Debt

ATRA$42M

EQ$0

Net Cash/Debt

ATRA$-38M

EQ$57M

Current Ratio (TTM)

ATRA1.98x

EQ23.40x

Quick Ratio (TTM)

ATRA1.98x

EQ23.07x

Debt/Equity (TTM)

ATRA0.12x

EQ0.00x

Debt/Assets (TTM)

ATRA0.0%

EQ0.0%

Interest Coverage (TTM)

ATRAN/A

EQN/A

Net Debt/EBITDA (TTM)

ATRA0.00x

EQ0.00x

Beta

ATRA0.31

EQ2.07

52W Performance

ATRA-40.2%

EQ-4.1%

YTD Performance

ATRA-46.7%

EQ-7.8%

% from 52W High

ATRA-50.5%

EQ-60.2%

% from 52W Low

ATRA141.8%

EQ85.5%

Asset Turnover (TTM)

ATRA0.27x

EQ1.12x

FCF Yield (TTM)

ATRA-25.6%

EQ-22.5%

Earnings Yield (TTM)

ATRA-19.5%

EQ-20.2%

Dividend Yield (TTM)

ATRAN/A

EQN/A

Rule of 40

ATRA-450.2

EQ0.0

EV/GP/RG

ATRA0.05

EQN/A

Ticker research

View ATRA research View EQ research

Metric	ATRA Atara Biotherapeutics Inc	EQ Equillium Inc
Market & Valuation
Market Cap	$85M	$89M
Enterprise Value	$124M	$32M
Price	$9.48	$1.41
P/E Ratio	N/A	N/A
P/S Ratio	13.79x	2.18x
EV/Sales	19.98x	0.78x
EV/EBITDA	3.51x	0.00x
P/B Ratio	12.86x	1.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.65x	-1.59x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	14.78x	N/A
Forward P/S (NTM)	2.47x	N/A
Revenue & Growth
Revenue (TTM)	$6M	$0
Revenue Growth (YoY)	-96.7%	N/A
Forward Rev Growth	1983.2%	0.0%
Profitability
Gross Margin (TTM)	91.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-194.7%	0.0%
Net Margin (TTM)	-269.4%	0.0%
FCF Margin (TTM)	-353.5%	N/A
Net Income (TTM)	$-17M	$-18M
FCF (TTM)	$-22M	$-20M
EPS (TTM)	-$1.11	-$0.15
ROE (TTM)	-31542.0%	-6143.0%
ROA (TTM)	-7301.0%	-5372.0%
ROIC (TTM)	-30684.0%	-6143.0%
Financial Health
Cash	$3M	$57M
Debt	$42M	$0
Net Cash/Debt	$-38M	$57M
Current Ratio (TTM)	1.98x	23.40x
Quick Ratio (TTM)	1.98x	23.07x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.31	2.07
52W Performance	-40.2%	-4.1%
YTD Performance	-46.7%	-7.8%
% from 52W High	-50.5%	-60.2%
% from 52W Low	141.8%	85.5%
Efficiency & Yields
Asset Turnover (TTM)	0.27x	1.12x
FCF Yield (TTM)	-25.6%	-22.5%
Earnings Yield (TTM)	-19.5%	-20.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-450.2	0.0
EV/GP/RG	0.05	N/A
Ticker research	View ATRA research	View EQ research